Skip to content

Advertisement

BMC Complementary and Alternative Medicine

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis

  • Manoj Parekh1, 2,
  • Girisha Ramaiah3,
  • Prachi Pashilkar3,
  • Ranjani Ramanujam4,
  • Peter Johnston5 and
  • Leodevico L. Ilag6, 7Email author
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201717:464

https://doi.org/10.1186/s12906-017-1970-2

Received: 14 July 2016

Accepted: 11 September 2017

Published: 18 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Jul 2016 Submitted Original manuscript
4 Nov 2016 Reviewed Reviewer Report - Shari Lipner
1 Dec 2016 Reviewed Reviewer Report - Punit Parejiya
1 Jan 2017 Author responded Author comments - Manoj Parekh
Resubmission - Version 2
1 Jan 2017 Submitted Manuscript version 2
7 Mar 2017 Reviewed Reviewer Report - Shari Lipner
7 Apr 2017 Reviewed Reviewer Report - Ignacio García- Doval
22 May 2017 Author responded Author comments - Manoj Parekh
Resubmission - Version 3
22 May 2017 Submitted Manuscript version 3
5 Jun 2017 Reviewed Reviewer Report - Shari Lipner
6 Sep 2017 Author responded Author comments - Manoj Parekh
Resubmission - Version 4
6 Sep 2017 Submitted Manuscript version 4
Publishing
11 Sep 2017 Editorially accepted
18 Sep 2017 Article published 10.1186/s12906-017-1970-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
The Apollo Clinic
(2)
Mahaveer Jain Hospital
(3)
Manipal AcuNova Ltd.
(4)
SPRIM India
(5)
Biovite Australia Pty Ltd.
(6)
Xerion Limited
(7)
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne

Advertisement